| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/14779072.6.5.641 |
| P698 | PubMed publication ID | 18510482 |
| P50 | author | Seppo Ylä-Herttuala | Q11893052 |
| Shalini Bhardwaj | Q125253455 | ||
| Himadri Roy | Q125255956 | ||
| P2860 | cites work | Insights into the pathogenesis of vein graft disease: lessons from intravascular ultrasound | Q24802948 |
| Improved gene delivery to human saphenous vein cells and tissue using a peptide-modified adenoviral vector | Q24804662 | ||
| Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics | Q28141424 | ||
| Neointima formation in a restenosis model is suppressed in midkine-deficient mice | Q28573235 | ||
| Single perivascular delivery of mitomycin C stimulates p21 expression and inhibits neointima formation in rat arteries | Q28574053 | ||
| Antisense oligonucleotides to c-fos and c-jun inhibit intimal thickening in a rat vein graft model | Q30756400 | ||
| Transcription inhibition induced by modified triple helix-forming oligonucleotides: a quantitative assay for evaluation in cells. | Q30979414 | ||
| Development of efficient viral vectors selective for vascular smooth muscle cells | Q33197377 | ||
| Cardiovascular gene therapy | Q33838040 | ||
| Lentiviral vectors: turning a deadly foe into a therapeutic agent | Q33840989 | ||
| Antithrombotic strategies in gene therapy | Q34027383 | ||
| Adeno-associated virus vectors for gene therapy: more pros than cons? | Q34080580 | ||
| Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides | Q34138108 | ||
| A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo | Q34159206 | ||
| Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy | Q34207550 | ||
| Genetic engineering of vein grafts resistant to atherosclerosis | Q34339752 | ||
| Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries | Q35054188 | ||
| Gene therapy for cardiovascular diseases | Q35668050 | ||
| Mouse model of venous bypass graft arteriosclerosis | Q35753478 | ||
| Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty | Q35766125 | ||
| Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response | Q35801091 | ||
| Attenuated herpes simplex virus 1 blocks arterial apoptosis and intimal hyperplasia induced by balloon angioplasty and reduced blood flow | Q35927978 | ||
| Release of soluble vascular endothelial growth factor receptor-1 (sFlt-1) during coronary artery bypass surgery | Q36083083 | ||
| Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation: a novel strategy to limit restenosis | Q36455617 | ||
| Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia | Q36534829 | ||
| The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. | Q51342662 | ||
| Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. | Q51826453 | ||
| Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein. | Q53659822 | ||
| Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. | Q54547681 | ||
| Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty | Q57243575 | ||
| Adenovirus-Mediated Gene Transfer of Placental Growth Factor to Perivascular Tissue Induces Angiogenesis via Upregulation of the Expression of Endogenous Vascular Endothelial Growth Factor-A | Q57382081 | ||
| Angiogenic Responses of Vascular Endothelial Growth Factors in Periadventitial Tissue | Q57382140 | ||
| Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts | Q37365179 | ||
| Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. | Q38290419 | ||
| Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy | Q38302443 | ||
| Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial | Q38318751 | ||
| Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo | Q38326202 | ||
| Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure | Q38330884 | ||
| In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction | Q38343941 | ||
| Prevention of restenosis by gene therapy | Q38346770 | ||
| Egr-1 target genes in human endothelial cells identified by microarray analysis | Q38349302 | ||
| Inhibition of adhesion molecule expression on human venous endothelial cells by non-viral siRNA transfection. | Q39739512 | ||
| Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly. | Q40122346 | ||
| Inhibition of carotis venous bypass graft disease by intraoperative nucleic acid-based therapy in rabbits | Q40289245 | ||
| Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1. | Q40429676 | ||
| Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells | Q40503865 | ||
| Optimization of nonviral transfection: variables influencing liposome-mediated gene transfer in proliferating vs. quiescent cells in culture and in vivo using a porcine restenosis model | Q40621359 | ||
| Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector | Q41055058 | ||
| Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein | Q43526519 | ||
| Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production | Q43746937 | ||
| Prevention of restenosis by a herpes simplex virus mutant capable of controlled long-term expression in vascular tissue in vivo | Q43873064 | ||
| Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses | Q43895883 | ||
| Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimal hyperplasia of vein grafts in cholesterol-fed rabbit: a limited biological effect as a result of the loss of medial smooth muscle cells | Q44035492 | ||
| Ultrasound-mediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model | Q44196487 | ||
| Gene transfer into the liver by plasmid injection into the portal vein combined with electroporation | Q44383527 | ||
| Sustained inhibition of experimental neointimal hyperplasia with a genetically modified herpes simplex virus | Q44452117 | ||
| Adenoviral delivery of a constitutively active retinoblastoma mutant inhibits neointima formation in a human explant model for vein graft disease | Q44623752 | ||
| Vein graft arterialization causes differential activation of mitogen-activated protein kinases. | Q44872730 | ||
| Lipoprotein lipase locus and progression of atherosclerosis in coronary-artery bypass grafts | Q45151927 | ||
| Influence of ischemic injury on vein graft remodeling: role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation. | Q45212048 | ||
| Extracellular superoxide dismutase with vaccinia virus anti-inflammatory protein 35K or tissue inhibitor of metalloproteinase-1: Combination gene therapy in the treatment of vein graft stenosis in rabbits | Q45417776 | ||
| Hemagglutinating virus of Japan-liposome-mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff | Q45757820 | ||
| Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo | Q45859529 | ||
| Application to vascular adventitia of a nonviral vector for TIMP-1 gene therapy to prevent intimal hyperplasia | Q45861097 | ||
| Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury | Q45861484 | ||
| Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts | Q45862185 | ||
| Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells | Q45874341 | ||
| Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy | Q45876899 | ||
| Analysis of cell-specific promoters for viral gene therapy targeted at the vascular endothelium | Q45878726 | ||
| Non-viral in vivo thrombomodulin gene transfer prevents early loss of thromboresistance of grafted veins | Q45879217 | ||
| p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion | Q45879229 | ||
| Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism | Q45881879 | ||
| Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. | Q45997933 | ||
| Morphologic findings in saphenous veins used as coronary arterial bypass conduits for longer than 1 year: necropsy analysis of 53 patients, 123 saphenous veins, and 1865 five-millimeter segments of veins | Q46078703 | ||
| VEGF-A, VEGF-D and VEGF-D(DeltaNDeltaC) induced intimal hyperplasia in carotid arteries | Q46790044 | ||
| Accelerated arteriosclerosis of vein grafts in inducible NO synthase(-/-) mice is related to decreased endothelial progenitor cell repair | Q46872632 | ||
| Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts | Q47420905 | ||
| Gene transfer to vein graft wall by HVJ-liposome method: time course and localization of gene expression. | Q50522324 | ||
| Antagonism of platelet-derived growth factor by perivascular gene transfer attenuates adventitial cell migration after vascular injury: new tricks for old dogs? | Q50726031 | ||
| P433 | issue | 5 | |
| P921 | main subject | gene therapy | Q213901 |
| P304 | page(s) | 641-652 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | Expert Review of Cardiovascular Therapy | Q15733727 |
| P1476 | title | Gene therapy to prevent occlusion of venous bypass grafts | |
| P478 | volume | 6 |
| Q45365539 | Adenovirus-Mediated Gene Transfer of microRNA-21 Sponge Inhibits Neointimal Hyperplasia in Rat Vein Grafts |
| Q35260617 | Development of viral vectors for use in cardiovascular gene therapy |
| Q91951475 | Exosomes derived from human umbilical cord mesenchymal stem cells inhibit vein graft intimal hyperplasia and accelerate reendothelialization by enhancing endothelial function |
| Q38081951 | Gene therapy for vein graft failure |
| Q35174913 | Helper-dependent adenoviral vector achieves prolonged, stable expression of interleukin-10 in rabbit carotid arteries but does not limit early atherogenesis |
| Q103756630 | MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation |
| Q41531960 | Preventing intimal thickening of vein grafts in vein artery bypass using STAT-3 siRNA. |
| Q39737214 | The dynamics of vein graft remodeling induced by hemodynamic forces: a mathematical model |
| Q36335468 | Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration |
Search more.